X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-31 | AXNX | Noblett Karen | Chief Medical Officer | S - Sale+OE | $67.74 | -11,288 | 34,428 | -25% | -$764,603 | |||||
2024-01-08 | AXNX | Noblett Karen | Chief Medical Officer | S - Sale | $69.00 | -15,999 | 18,216 | -47% | -$1,103,961 | ||||||
| M | 2023-12-26 | AXNX | Noblett Karen | Chief Medical Officer | S - Sale | $63.25 | -8,000 | 34,215 | -19% | -$505,964 | |||||
| DM | 2023-01-31 | AXNX | Noblett Karen | Chief Medical Officer | S - Sale+OE | $61.11 | -4,634 | 42,215 | -10% | -$283,164 | |||||
| D | 2022-09-12 | AXNX | Noblett Karen | Chief Medical Officer | S - Sale+OE | $78.16 | -32,483 | 31,599 | -51% | -$2,538,800 | |||||
2022-09-07 | AXNX | Noblett Karen | Chief Medical Officer | S - Sale | $71.53 | -10,454 | 31,599 | -25% | -$747,794 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |